Samchundang Pharma Crashes 86% From Peak, Hits Daily Limit on July 21

According to Herald Economy, Samchundang Pharma plunged to its daily limit on July 21, down 86% from its recent high. The South Korean pharmaceutical company, which previously ranked as the top market cap stock on KOSDAQ and surged on expectations for its oral obesity treatment, saw the majority of retail investors enter loss territory following the sharp decline.
Disclaimer: The information on this page may come from third-party sources and is for reference only. It does not represent the views or opinions of Gate and does not constitute any financial, investment, or legal advice. Virtual asset trading involves high risk. Please do not rely solely on the information on this page when making decisions. For details, see the Disclaimer.
Comment
0/400
No comments